Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-23-024914)

Filing Details

Accession Number:: 0001209191-23-024914
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-04-19 19:06:14
Reporting Period:: 2023-04-17

Accepted Time:: 2023-04-19 19:06:14
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1679363	Morphic Holding Inc.	MORF	Pharmaceutical Preparations (2834)	473878772

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1780273	Bruce Rogers	C/O Morphic Holding, Inc. 35 Gatehouse Drive, A2 Waltham MA 02451	President	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-04-17	10,000	$4.32	127,055	No	4	M	Direct
Common Stock	Disposition	2023-04-17	10,000	$40.35	117,055	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy Common Stock)	Disposition	2023-04-17	10,000	$0.00	10,000	$4.32

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
128,114		2028-12-14	No	4	M	Direct

Footnotes

Includes 863 shares of Common Stock acquired under the issuer's employee stock purchase plan on February 28, 2023.
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
The option is fully vested.